位置:首页 > 蛋白库 > POMT1_MOUSE
POMT1_MOUSE
ID   POMT1_MOUSE             Reviewed;         746 AA.
AC   Q8R2R1; Q3UYD8; Q64J18; Q8BPJ6; Q8BPU1; Q8R474;
DT   20-JUN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   03-AUG-2022, entry version 155.
DE   RecName: Full=Protein O-mannosyl-transferase 1;
DE            EC=2.4.1.109;
DE   AltName: Full=Dolichyl-phosphate-mannose--protein mannosyltransferase 1;
GN   Name=Pomt1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ;
RA   Wang X., Jigami Y.;
RT   "A putative mouse O-mannosyltransferase mPOMT1.";
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], DEVELOPMENTAL STAGE, AND DISRUPTION PHENOTYPE.
RC   STRAIN=Swiss Webster / NIH; TISSUE=Embryo;
RX   PubMed=15383666; DOI=10.1073/pnas.0405899101;
RA   Willer T., Prados B., Falcon-Perez J.M., Renner-Mueller I.,
RA   Przemeck G.K.H., Lommel M., Coloma A., Valero M.C., De Angelis M.H.,
RA   Tanner W., Wolf E., Strahl S., Cruces J.;
RT   "Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse
RT   results in embryonic lethality.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:14126-14131(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Eye, Medulla oblongata, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Transfers mannosyl residues to the hydroxyl group of serine
CC       or threonine residues. Coexpression of both POMT1 and POMT2 is
CC       necessary for enzyme activity, expression of either POMT1 or POMT2
CC       alone is insufficient. Essentially dedicated to O-mannosylation of
CC       alpha-DAG1 and few other proteins but not of cadherins and
CC       protocaherins. {ECO:0000250|UniProtKB:Q9Y6A1}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a dolichyl beta-D-mannosyl phosphate + L-seryl-[protein] = 3-
CC         O-(alpha-D-mannosyl)-L-seryl-[protein] + a dolichyl phosphate + H(+);
CC         Xref=Rhea:RHEA:17377, Rhea:RHEA-COMP:9517, Rhea:RHEA-COMP:9527,
CC         Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:13546, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29999, ChEBI:CHEBI:57683, ChEBI:CHEBI:58211,
CC         ChEBI:CHEBI:137321; EC=2.4.1.109;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6A1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a dolichyl beta-D-mannosyl phosphate + L-threonyl-[protein] =
CC         3-O-(alpha-D-mannosyl)-L-threonyl-[protein] + a dolichyl phosphate +
CC         H(+); Xref=Rhea:RHEA:53396, Rhea:RHEA-COMP:9517, Rhea:RHEA-COMP:9527,
CC         Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:13547, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30013, ChEBI:CHEBI:57683, ChEBI:CHEBI:58211,
CC         ChEBI:CHEBI:137323; EC=2.4.1.109;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y6A1};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250};
CC       Multi-pass membrane protein {ECO:0000250}.
CC   -!- DEVELOPMENTAL STAGE: Expressed ubiquitously at low level after 7.5 dpc.
CC       At 8.5 dpc high levels of expression are detected throughout the neural
CC       tube, and in the dorsal aspects of the neural folds of the future
CC       midbrain region and the somites. At 9.0 dpc high levels of expression
CC       are detected in the ventral domain of the neural tube, developing eye,
CC       floor plate, notochord, and gut endothelium. At 10.5 dpc expression
CC       high levels of expression are detected in the dermomyotome of the
CC       somites, limb-bud mesenchyme, mantle layer of the dorsal neural tube,
CC       and developing trigeminal ganglion. {ECO:0000269|PubMed:15383666}.
CC   -!- DISRUPTION PHENOTYPE: Mice suffer of developmental arrest around 7.5
CC       dpc and die between 7.5 dpc and 9.5 dpc. Defects are observed in the
CC       formation of Reichert's membrane that are probably due to abnormal
CC       glycosylation and maturation of dystroglycan and impaired recruitment
CC       of laminin. {ECO:0000269|PubMed:15383666}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 39 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC35577.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY007238; AAG15588.1; -; mRNA.
DR   EMBL; AY494857; AAS76201.1; -; mRNA.
DR   EMBL; AK053889; BAC35577.1; ALT_FRAME; mRNA.
DR   EMBL; AK134770; BAE22274.1; -; mRNA.
DR   EMBL; AK153984; BAE32295.1; -; mRNA.
DR   EMBL; BC027325; AAH27325.1; -; mRNA.
DR   CCDS; CCDS15908.1; -.
DR   RefSeq; NP_660127.1; NM_145145.1.
DR   AlphaFoldDB; Q8R2R1; -.
DR   SMR; Q8R2R1; -.
DR   STRING; 10090.ENSMUSP00000038722; -.
DR   CAZy; GT39; Glycosyltransferase Family 39.
DR   GlyConnect; 2639; 3 N-Linked glycans (1 site).
DR   GlyGen; Q8R2R1; 3 sites, 3 N-linked glycans (1 site).
DR   PhosphoSitePlus; Q8R2R1; -.
DR   EPD; Q8R2R1; -.
DR   MaxQB; Q8R2R1; -.
DR   PaxDb; Q8R2R1; -.
DR   PeptideAtlas; Q8R2R1; -.
DR   PRIDE; Q8R2R1; -.
DR   ProteomicsDB; 289786; -.
DR   Antibodypedia; 31602; 191 antibodies from 27 providers.
DR   DNASU; 99011; -.
DR   Ensembl; ENSMUST00000036473; ENSMUSP00000038722; ENSMUSG00000039254.
DR   GeneID; 99011; -.
DR   KEGG; mmu:99011; -.
DR   UCSC; uc008jeq.1; mouse.
DR   CTD; 10585; -.
DR   MGI; MGI:2138994; Pomt1.
DR   VEuPathDB; HostDB:ENSMUSG00000039254; -.
DR   eggNOG; KOG3359; Eukaryota.
DR   GeneTree; ENSGT00940000158049; -.
DR   HOGENOM; CLU_008438_1_0_1; -.
DR   InParanoid; Q8R2R1; -.
DR   OMA; FWTQNDT; -.
DR   OrthoDB; 203029at2759; -.
DR   PhylomeDB; Q8R2R1; -.
DR   TreeFam; TF300552; -.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 99011; 1 hit in 71 CRISPR screens.
DR   ChiTaRS; Pomt1; mouse.
DR   PRO; PR:Q8R2R1; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q8R2R1; protein.
DR   Bgee; ENSMUSG00000039254; Expressed in spermatocyte and 254 other tissues.
DR   ExpressionAtlas; Q8R2R1; baseline and differential.
DR   Genevisible; Q8R2R1; MM.
DR   GO; GO:0001669; C:acrosomal vesicle; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:MGI.
DR   GO; GO:0004169; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000030; F:mannosyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; IMP:MGI.
DR   GO; GO:1904100; P:positive regulation of protein O-linked glycosylation; ISO:MGI.
DR   GO; GO:0035269; P:protein O-linked mannosylation; ISS:UniProtKB.
DR   InterPro; IPR027005; GlyclTrfase_39-like.
DR   InterPro; IPR003342; Glyco_trans_39/83.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR032421; PMT_4TMC.
DR   PANTHER; PTHR10050; PTHR10050; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF02366; PMT; 1.
DR   Pfam; PF16192; PMT_4TMC; 1.
DR   SMART; SM00472; MIR; 3.
DR   SUPFAM; SSF82109; SSF82109; 1.
DR   PROSITE; PS50919; MIR; 3.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Glycoprotein; Glycosyltransferase; Membrane;
KW   Reference proteome; Repeat; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..746
FT                   /note="Protein O-mannosyl-transferase 1"
FT                   /id="PRO_0000121485"
FT   TRANSMEM        30..50
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        90..110
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        121..141
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        144..164
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        176..196
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        228..248
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        266..286
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        597..617
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        636..656
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        660..680
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          318..381
FT                   /note="MIR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          392..449
FT                   /note="MIR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          453..513
FT                   /note="MIR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   CARBOHYD        435
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        471
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        539
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        2
FT                   /note="G -> S (in Ref. 3; BAC35577)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        257
FT                   /note="R -> P (in Ref. 1; AAG15588)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        318
FT                   /note="P -> H (in Ref. 3; BAE22274)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        330
FT                   /note="K -> E (in Ref. 1; AAG15588)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   746 AA;  85234 MW;  05CB97DFC79BAE0A CRC64;
     MGSHSTGLEE TLGVLPSWLF CKMLRFLKRP LVVTVDINLN LVALTGLGLL TRLWQLSYPR
     AVVFDEVYYG QYISFYMKRI FFLDDSGPPF GHMLLALGGW LGGFDGNFLW NRIGAEYSSN
     VPIWSLRLLP ALAGALSVPM AYQIVLELHF SHGAAIGAAL LMLIENALIT QSRLMLLESI
     LIFFNLLAVL SYLKFFNSQT HSPFSVHWWL WLLLTGVSCS CAVGIKYMGI FTYLLVLGIA
     AVHAWNLIGD QTLSNMRVLS HLLARIVALL VVPVFLYLLF FYVHLMLLYR SGPHDQIMSS
     AFQASLEGGL ARITQGQPLE VAFGSQVTLK SVSGKPLPCW LHSHKNTYPM IYENGRGSSH
     QQQVTCYPFK DINNWWIVKD PGRHQLVVNN PPRPVRHGDI VQLVHGMTTR LLNTHDVAAP
     LSPHSQEVSC YIDYNISMPA QNLWKLDIVN RESNRDTWKT ILSEVRFVHV NTSAILKLSG
     AHLPDWGFRQ LEVVGEKLSP GYHESMVWNV EEHRYGKSHE QKERELELHS PTQLDISRNL
     SFMARFSELQ WKMLTLKNED LEHQYSSTPL EWLTLDTNIA YWLHPRTSAQ IHLLGNIVIW
     TSASLATVVY TLLFFWYLLR RRRSICDLPE DAWSRWVLAG ALCTGGWALN YLPFFLMERV
     LFLYHYLPAL TFQILLLPIV LQHASDHLCR SQLQRNVFSA LVVAWYSSAC HVSNMLRPLT
     YGDTSLSPGE LRALRWKDSW DILIRK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024